Kazuko Kaneda-Nakashima

15PUBLICATIONS
34CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsSolid tumoursAutomotive combustion and fuel engineeringAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 14, 2026
Flavonoid Interactions with Renal Organic Anion Transporters OAT1 and OAT3: Structure-Activity Relationships and Clinical Implications.

Kai Tong, Pinmao Ye, Kazuko Kaneda-Nakashima

|Nov 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer.

Sifan Feng, Kentaro Hisada, Haruna Yorifuji

|Sep 13, 2025
LAT1-Targeted Alpha Therapy Using 211At-AAMT for Bone and Soft Tissue Sarcomas.

Haruna Takami, Yoshinori Imura, Hidetatsu Outani

|Nov 27, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Kentaro Hisada

|Nov 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami

Pageof 3